We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Fortress Biotech (FBIO) Catches Eye: Stock Moves Up 8.3%
Fortress Biotech, Inc. (FBIO - Free Report) was a big mover last session, as its shares rose over 8% on the day. The move came after the company reported encouraging fourth-quarter and full-year 2016 results. This also led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 37% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Fortress Biotech currently carries a Zacks Rank #3 (Hold).
Fortress Biotech, Inc. Price
Fortress Biotech, Inc. Price | Fortress Biotech, Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics space is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) , carrying a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this Watch List today for free >>